You just read:

National Center for Child Health and Development Initiates Phase 1/2 Trial of Green Cross' idursulfase-beta ICV for the Treatment of Hunter Syndrome with Neurocognitive Decline

News provided by

Green Cross Corporation

26 Oct, 2016, 03:54 BST